Article

PCSK9 inhibition in patients with heart failure: neutral or harmful intervention?

European Heart Journal
DOI: 10.1093/eurheartj/ehab913
5Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Niessner, A., & Drexel, H. (2022, April 21). PCSK9 inhibition in patients with heart failure: neutral or harmful intervention? European Heart Journal. Oxford University Press. https://doi.org/10.1093/eurheartj/ehab913

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free